{
    "title": "U.S. FDA advisers back Ardelyx's kidney disease drug",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11436839/U-S-FDA-advisers-Ardelyxs-kidney-disease-drug.html",
    "date": "2022-11-16",
    "keywords": [
        "drug",
        "panel",
        "kidney",
        "year",
        "leo",
        "mandowara",
        "disease",
        "dialysis",
        "favor",
        "tenapanor",
        "therapy",
        "phosphate",
        "blood",
        "member",
        "meeting",
        "health",
        "regulator",
        "wednesday",
        "approval",
        "food",
        "treatment",
        "level",
        "body",
        "pathway",
        "hyperphosphatemia",
        "condition",
        "phosphorus",
        "sign",
        "damage",
        "government",
        "report",
        "nothing",
        "c",
        "merz",
        "center",
        "release",
        "monday",
        "staff",
        "agency",
        "response",
        "letter",
        "july",
        "fda",
        "appeal",
        "rejection",
        "ardelyx",
        "officer",
        "mike",
        "raab",
        "decision",
        "conclusion",
        "reporting",
        "khushi",
        "editing",
        "krishna",
        "chandra",
        "eluri",
        "kuber"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}